mitoxantrone has been researched along with Carcinoma, Non-Small Cell Lung in 14 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with mitoxantrone also led to the appearance of structures resembling agresomes in H1299 cells and to nucleolar segregation in both cell lines." | 1.43 | Cytoskeletal reorganization and cell death in mitoxantrone-treated lung cancer cells. ( Gackowska, L; Grzanka, A; Klimaszewska-Wisniewska, A; Pawlik, A; Szczepanski, MA; Zuryn, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Y | 1 |
| Pang, H | 1 |
| Yu, Z | 1 |
| Wang, X | 2 |
| Li, P | 1 |
| Zhang, Q | 1 |
| Liu, H | 1 |
| Kuang, X | 1 |
| Zhang, Y | 2 |
| Ye, Y | 1 |
| Li, J | 1 |
| Liang, L | 1 |
| Xie, Z | 1 |
| Weng, L | 1 |
| Guo, J | 1 |
| Li, H | 1 |
| Ma, F | 1 |
| Chen, X | 2 |
| Zhao, S | 1 |
| Su, J | 1 |
| Yang, N | 1 |
| Fang, F | 1 |
| Xie, Y | 1 |
| Tao, J | 1 |
| Zhang, J | 1 |
| Chen, M | 1 |
| Peng, C | 1 |
| Sun, L | 1 |
| Zhang, X | 1 |
| Liu, J | 1 |
| Han, L | 2 |
| Xu, X | 1 |
| Hung, MC | 1 |
| Hussein, N | 1 |
| Amawi, H | 1 |
| Karthikeyan, C | 1 |
| Hall, FS | 1 |
| Mittal, R | 1 |
| Trivedi, P | 1 |
| Ashby, CR | 2 |
| Tiwari, AK | 1 |
| Zhang, B | 1 |
| Fu, D | 1 |
| Xu, Q | 1 |
| Cong, X | 1 |
| Wu, C | 1 |
| Zhong, X | 1 |
| Ma, Y | 1 |
| Lv, Z | 1 |
| Chen, F | 1 |
| Qian, M | 1 |
| Chin, YE | 1 |
| Lam, EW | 1 |
| Chiao, P | 1 |
| Sun, Y | 1 |
| Ji, N | 1 |
| Yang, Y | 1 |
| Cai, CY | 1 |
| Lei, ZN | 1 |
| Wang, JQ | 1 |
| Gupta, P | 1 |
| Shukla, S | 2 |
| Ambudkar, SV | 2 |
| Kong, D | 1 |
| Chen, ZS | 2 |
| Zhang, H | 1 |
| Kathawala, RJ | 1 |
| Wang, YJ | 1 |
| Zhang, YK | 1 |
| Patel, A | 1 |
| Robey, RW | 1 |
| Talele, TT | 1 |
| Bates, SE | 1 |
| Fu, LW | 1 |
| Pawlik, A | 1 |
| Szczepanski, MA | 1 |
| Klimaszewska-Wisniewska, A | 1 |
| Gackowska, L | 1 |
| Zuryn, A | 1 |
| Grzanka, A | 1 |
| Zhang, W | 1 |
| Chen, Z | 1 |
| Chen, L | 1 |
| Wang, F | 1 |
| Li, F | 1 |
| Fu, L | 1 |
| Noguchi, K | 1 |
| Kawahara, H | 1 |
| Kaji, A | 1 |
| Katayama, K | 1 |
| Mitsuhashi, J | 1 |
| Sugimoto, Y | 1 |
| Byun, Y | 1 |
| Ren, YR | 1 |
| Liu, JO | 1 |
| Laterra, J | 1 |
| Pomper, MG | 1 |
| Bram, EE | 1 |
| Ifergan, I | 1 |
| Grimberg, M | 1 |
| Lemke, K | 1 |
| Skladanowski, A | 1 |
| Assaraf, YG | 1 |
| Feun, LG | 1 |
| Savaraj, N | 1 |
| Solomon, J | 1 |
| Liebmann, A | 1 |
| Hurley, J | 1 |
| O'Connor, BM | 1 |
| Ziegler, P | 1 |
| Spaulding, MB | 1 |
| Giaccone, G | 1 |
2 trials available for mitoxantrone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Phase II trial of mitoxantrone and cisplatin in advanced non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 1996 |
Excessive toxicity of mitoxantrone combined with etoposide in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Ev | 1991 |
12 other studies available for mitoxantrone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Construction of inflammatory associated risk gene prognostic model of NSCLC and its correlation with chemotherapy sensitivity.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Mitoxantrone; Oxaliplatin; Prognosis | 2023 |
ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis.
Topics: Activating Transcription Factor 3; Adenosine A1 Receptor Antagonists; Adult; Aged; Animals; Antineop | 2020 |
The dopamine D
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Benzamides; Carcinoma, Non-Small-Cell Lung; | 2017 |
The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Non-Small-Cell Lung; | 2018 |
Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.
Topics: Adenosine Triphosphatases; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic | 2019 |
Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10-mediated drug resistance.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette | 2014 |
Cytoskeletal reorganization and cell death in mitoxantrone-treated lung cancer cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Death; Cell Line, Tumor; Cytoskeleton; H | 2016 |
ABCG2-overexpressing H460/MX20 cell xenografts in athymic nude mice maintained original biochemical and cytological characteristics.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Carcinoma, | 2017 |
Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily | 2009 |
Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding | 2009 |
C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cells.
Topics: Acridines; Aminoacridines; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Mem | 2007 |
The European Organization for Research and Treatment of Cancer (EORTC) trials of new agents for advanced non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Ellipticines; Female; Humans; Lung Neoplasms; | 1988 |